Litigation Details for SANTEN PHARMACEUTICAL CO. LTD. v. MICRO LABS LIMITED (D.N.J. 2018)
✉ Email this page to a colleague
SANTEN PHARMACEUTICAL CO. LTD. v. MICRO LABS LIMITED (D.N.J. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-08-01 |
| Court | District Court, D. New Jersey | Date Terminated | 2018-10-24 |
| Cause | 35:271 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Parties | MICRO LABS USA INC. | ||
| Patents | 9,999,593 | ||
| Attorneys | RAVIN R. PATEL | ||
| Firms | Ravin R. Patel | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SANTEN PHARMACEUTICAL CO. LTD. v. MICRO LABS LIMITED
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for SANTEN PHARMACEUTICAL CO. LTD. v. MICRO LABS LIMITED (D.N.J. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-08-01 | 1 | Complaint | to the expiration of U.S. Patent No. 9,999,593 (“the ’593 Patent” or “patent-in-suit”). 2. …Book-listed patent for ZIOPTAN® at the time, i.e., U.S. Patent No. 5,886,035 (“the ’035 Patent”), and certain… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE ’593 PATENT AND ZIOPTAN 15. On June 19, 2018, the United States Patent and Trademark…review pharmaceutical patents and seek opportunities to challenge those patents. 21. On information | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
